Abstract
During the last decades, tremendous chemical efforts have been dedicated to design monovalent inhibitors of carbohydrate-processing enzymes, with comparatively few rewards in terms of marketed drugs. Recently, an alternative to the traditional "lock and key" approach has emerged. Multivalency, a widely used strategy for lectin inhibition, has been successfully applied to specific glycosidases and glycosyltransferases.
Keywords:
carbohydrates; drug design; enzymes; inhibitors.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
MeSH terms
-
Animals
-
Carbohydrate Metabolism*
-
Carbohydrates / chemistry*
-
Drug Design
-
Enzyme Inhibitors / chemistry*
-
Enzyme Inhibitors / pharmacology*
-
Glycoside Hydrolases / antagonists & inhibitors*
-
Glycoside Hydrolases / chemistry
-
Glycoside Hydrolases / metabolism
-
Humans
-
Models, Molecular
-
Neuraminidase / antagonists & inhibitors*
-
Neuraminidase / chemistry
-
Neuraminidase / metabolism
-
Structure-Activity Relationship
-
alpha-Mannosidase / antagonists & inhibitors*
-
alpha-Mannosidase / chemistry
-
alpha-Mannosidase / metabolism
Substances
-
Carbohydrates
-
Enzyme Inhibitors
-
Glycoside Hydrolases
-
Neuraminidase
-
alpha-Mannosidase